Showing results (1-10 of 259) with videos related to
Sort By:
Pageof 26
Current Opinion in HIV and AIDS|September 15, 2023
Control groups for HIV prevention efficacy trials: what does the future hold?Holly Janes, Susan BuchbinderStatistics in Medicine|March 5, 2025
Active-Controlled Trial Design for HIV Prevention Trials With a Counterfactual PlaceboFei Gao, Holly Janes, Susan Buchbinder, et al.AIDS Research and Human Retroviruses|April 20, 2013
In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalitiesHolly Janes, Peter Gilbert, Susan Buchbinder, et al.Biostatistics (Oxford, England)|January 24, 2006
The optimal ratio of cases to controls for estimating the classification accuracy of a biomarkerHolly Janes, Margaret PepeTopics in HIV Medicine : a Publication of the International AIDS Society, USA|April 28, 2006
Epidemiology and preventionSusan BuchbinderTopics in HIV Medicine : a Publication of the International AIDS Society, USA|April 29, 2008
Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. HIV testing and prevention strategiesSusan BuchbinderTopics in HIV Medicine : a Publication of the International AIDS Society, USA|May 9, 2007
HIV epidemiology and prevention interventionsSusan BuchbinderTopics in HIV Medicine : a Publication of the International AIDS Society, USA|June 3, 2010
HIV epidemiology, testing strategies, and prevention interventionsSusan BuchbinderTopics in HIV Medicine : a Publication of the International AIDS Society, USA|April 30, 2009
The epidemiology of new HIV infections and interventions to limit HIV transmissionSusan BuchbinderBiostatistics (Oxford, England)|November 7, 2006
Insights into latent class analysis of diagnostic test performanceMargaret Sullivan Pepe, Holly JanesPageof 26